Prescribing Update Newsletter – April 2024

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on the latest of our Strategic Insights publications “Social Prescribing: Evidence and Outcomes”, and our Medicines in Practice publication “Optimised prescribing of oral iron supplements for iron deficiency anaemia”. It also includes information on some key medicines availability issues, the dates of our upcoming demo and Q&A sessions on RDTC reports, publications, and resources, and another in the series of “Meet the Team” where you can get to know the people behind the work we do.

View the preview below on desktop, or click here to download a copy

Prescribing Update Newsletter – March 2024

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on recent RDTC publications and the dates of our upcoming demo and Q&A sessions on RDTC reports, publications, and resources.

View the preview below on desktop, or click here to download a copy

Prescribing Update Newsletter – February 2024

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on the added features and updates to the RDTC Medicines Optimisation Opportunities Dashboard, and the updated version of the Inhaler Carbon Impact Assessment Tool. It also includes information on some key medicines availability issues, the dates of our upcoming demo and Q&A sessions on RDTC reports, publications, and resources, and another in the series of “Meet the Team” where you can get to know the people behind the work we do.

View the preview below on desktop, or click here to download a copy

Prescribing Update Newsletter – December 2023

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on our new NHS Medicines Optimisation Opportunities Dashboard, and our Strategic Insight publication: Defining the type-2 diabetic population: a first step to understanding the impact of pathway choices. There is also information on serious shortage protocols, some key medicines availability issues, and the dates of our upcoming demo and Q&A sessions on RDTC reports, publications, and resources.  It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do.

View the preview below on desktop, or click here to download a copy.

Prescribing Update Newsletter – September 2023

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on our Medicine Value bulletins, the environmental impact of inhaler disposal, and the recent National Patient Safety Alert on the shortage of ADHD medications. It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on serious shortage protocols, some key medicines availability issues, UK product launches, and the RDTC attendance at the forthcoming Clinical Pharmacy Congress (CPC) in November.

View the preview below on desktop, or click here to download a copy.

July 2023 Newsletter

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on the budget impact of methylphenidate modified release tablet choice, the effect of price concessions on prescribing budgets, and changes to the shingles vaccination programme. It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on serious shortage protocols, some key medicines availability, new and updated NICE guidance, and UK product launches.

View the preview below on desktop, or click here to download a copy.

April 2023 Newsletter

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on semaglutide for managing overweight and obesity, Familial Hypercholesterolaemia Gene Testing Workshops, a new NHSE short course on working with people and communities, recent publications from the RDTC, and an update on the RDTC prescribing support team attendance at the GNPRC Conference in July 2023. It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on some key medicines availability, new and updated NICE guidance, and UK product launches.

February 2023 Newsletter

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on RDTC resources to help you make the most of your budget, updates to the cost comparison charts, the voluntary recall of certain FreeStyle Libre 2 sensors, and an E-learning programme on internet safety, suicide, and self-harm. It highlights recent publications from the RDTC including a series of publications as part of the Polypharmacy and Overprescribing theme reviewing opioid prescribing, and a Prescribing Bulletin looking at the budget impact of Metformin immediate release 1g tablets. It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on some key medicines availability issues and serious shortage protocols

Prescribing for Population Health – Polypharmacy and Overprescribing: Opioids

In recent years, there has been increasing concern regarding the overprescribing of opioids and associated harms. The RDTC has produced a series of publications as part of the Polypharmacy and Overprescribing theme reviewing opioid prescribing:

Each publication includes considerations and interventions for medicines optimisation teams and health systems. To avoid duplication across this series of overprescribing and polypharmacy opioid publications, the suggested actions have only been listed in the most relevant theme but may apply across all. We recommend reading all parts of the series sequentially to ensure the breadth of potential actions are known. The publications can be accessed using the links below:

PPH 3. Polypharmacy & Overprescribing: Opioid patient populations:

This publication aims to support greater understanding of the patient populations prescribed opioids and the inter-relationships and dependencies between prescribing and the available metrics.

PPH 4. Polypharmacy & Overprescribing: Opioid patient demographics:

This publication aims to support greater understanding of the demographics of the patient populations prescribed opioids.

PPH 5. Opioid population health management:

This publication aims to support greater understanding of the population health management of patients prescribed opioids, specifically in terms of deprivation level and the impact on sustainability and climate change.

December 2022 Newsletter

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on polypharmacy, influenza in the community – prescribing antivirals, group A streptococcus in children – advice for clinicians, and the MHRA review on the safe use of valproate. We also include recent publications from the RDTC and another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on some key medicines availability issues and serious shortage protocols.